GetTopicDetailResponse(id=90d284e7c0, topicName=harvoni, introduction=harvoni, content=null, image=null, comments=5, allHits=1466, url=https://h5.medsci.cn/topic?id=8477, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=33782, tagList=[TagDto(tagId=33782, tagName=harvoni)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1479738, encodeId=ea5d14e97386a, content=<a href='/topic/show?id=90d284e7c0' target=_blank style='color:#2F92EE;'>#harvoni#</a>, objectTitle=AIM：Harvoni治療HCV感染的腎移植受者的療效研究, objectType=article, longId=82664, objectId=cb7b82664df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb7b82664df, replyNumber=0, likeNumber=154, createdTime=2016-11-20, rootId=0, userName=124987c6m38暫無昵稱, userId=d80a7571256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb7b82664df, moduleTitle=AIM：Harvoni治療HCV感染的腎移植受者的療效研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cb7b82664df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479737, encodeId=778214e97375f, content=<a href='/topic/show?id=90d284e7c0' target=_blank style='color:#2F92EE;'>#harvoni#</a>, objectTitle=ILC 2016：Harvoni治療腎移植的HCV患者仍安全有效, objectType=article, longId=66808, objectId=a992668086e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a992668086e, replyNumber=0, likeNumber=88, createdTime=2016-04-21, rootId=0, userName=124987c6m38暫無昵稱, userId=d80a7571256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a992668086e, moduleTitle=ILC 2016：Harvoni治療腎移植的HCV患者仍安全有效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a992668086e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479736, encodeId=afdf14e973641, content=<a href='/topic/show?id=90d284e7c0' target=_blank style='color:#2F92EE;'>#harvoni#</a>, objectTitle=ILC 2016：Harvoni對青少年HCV依然高度有效, objectType=article, longId=66615, objectId=688a6661543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=688a6661543, replyNumber=0, likeNumber=83, createdTime=2016-04-19, rootId=0, userName=124987c6m38暫無昵稱, userId=d80a7571256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=688a6661543, moduleTitle=ILC 2016：Harvoni對青少年HCV依然高度有效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=688a6661543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479735, encodeId=b87e14e9735dc, content=<a href='/topic/show?id=90d284e7c0' target=_blank style='color:#2F92EE;'>#harvoni#</a>, objectTitle=吉利德丙肝藥物Harvoni獲歐盟上市許可, objectType=article, longId=43045, objectId=f673430454f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f673430454f, replyNumber=0, likeNumber=125, createdTime=2014-11-26, rootId=0, userName=124987c6m38暫無昵稱, userId=d80a7571256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f673430454f, moduleTitle=吉利德丙肝藥物Harvoni獲歐盟上市許可, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f673430454f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479734, encodeId=602514e9734e6, content=<a href='/topic/show?id=90d284e7c0' target=_blank style='color:#2F92EE;'>#harvoni#</a>, objectTitle=喜大普奔！吉利德丙肝雞尾酒Harvoni獲FDA批準(zhǔn)！, objectType=article, longId=41187, objectId=3e0f4118ec0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e0f4118ec0, replyNumber=0, likeNumber=82, createdTime=2014-10-15, rootId=0, userName=124987c6m38暫無昵稱, userId=d80a7571256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e0f4118ec0, moduleTitle=喜大普奔！吉利德丙肝雞尾酒Harvoni獲FDA批準(zhǔn)！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3e0f4118ec0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
